JPS55110557A - Tissue adhesive and its preparation - Google Patents

Tissue adhesive and its preparation

Info

Publication number
JPS55110557A
JPS55110557A JP1378380A JP1378380A JPS55110557A JP S55110557 A JPS55110557 A JP S55110557A JP 1378380 A JP1378380 A JP 1378380A JP 1378380 A JP1378380 A JP 1378380A JP S55110557 A JPS55110557 A JP S55110557A
Authority
JP
Japan
Prior art keywords
preparation
tissue adhesive
tissue
adhesive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1378380A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6340547B2 (cg-RX-API-DMAC7.html
Inventor
Shiyubuarutsu Otsutoo
Rinnau Iendora
Reepuritsuhi Furantsu
Zeeritsuhi Toomasu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3508554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS55110557(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno AG filed Critical Immuno AG
Publication of JPS55110557A publication Critical patent/JPS55110557A/ja
Publication of JPS6340547B2 publication Critical patent/JPS6340547B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Adhesives Or Adhesive Processes (AREA)
JP1378380A 1979-02-15 1980-02-08 Tissue adhesive and its preparation Granted JPS55110557A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT119079A AT359653B (de) 1979-02-15 1979-02-15 Verfahren zur herstellung eines gewebekleb- stoffes

Publications (2)

Publication Number Publication Date
JPS55110557A true JPS55110557A (en) 1980-08-26
JPS6340547B2 JPS6340547B2 (cg-RX-API-DMAC7.html) 1988-08-11

Family

ID=3508554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1378380A Granted JPS55110557A (en) 1979-02-15 1980-02-08 Tissue adhesive and its preparation

Country Status (15)

Country Link
US (2) US4298598A (cg-RX-API-DMAC7.html)
JP (1) JPS55110557A (cg-RX-API-DMAC7.html)
AR (2) AR222209A1 (cg-RX-API-DMAC7.html)
AT (1) AT359653B (cg-RX-API-DMAC7.html)
BE (1) BE881467A (cg-RX-API-DMAC7.html)
CA (1) CA1119516A (cg-RX-API-DMAC7.html)
CH (1) CH649925A5 (cg-RX-API-DMAC7.html)
DE (1) DE3002933C2 (cg-RX-API-DMAC7.html)
DK (1) DK151611B (cg-RX-API-DMAC7.html)
ES (1) ES488431A0 (cg-RX-API-DMAC7.html)
FR (1) FR2448901A1 (cg-RX-API-DMAC7.html)
GB (1) GB2042556B (cg-RX-API-DMAC7.html)
IT (1) IT1141212B (cg-RX-API-DMAC7.html)
NL (1) NL190748B (cg-RX-API-DMAC7.html)
SE (2) SE453800B (cg-RX-API-DMAC7.html)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826821A (ja) * 1981-07-28 1983-02-17 イムノ・アクチェンゲゼルシャフト 組織接着剤並びにその製造方法
JPS6324951A (ja) * 1986-07-05 1988-02-02 ベ−リングヴエルケ・アクチエンゲゼルシヤフト 一成分組織接着剤およびその製造方法
JPH0196138A (ja) * 1987-10-06 1989-04-14 Green Cross Corp:The 異常破水治療剤
JPH01250326A (ja) * 1988-03-31 1989-10-05 Chemo Sero Therapeut Res Inst ヒト血漿由来血液凝固第ｘ３因子の製造方法
JPH02114A (ja) * 1987-07-30 1990-01-05 Centre Reg Transfusion Sanguine De Lille トロンビン凝固性蛋白質の濃縮物、その製造方法及びその治療的用途
JPH06507376A (ja) * 1990-07-27 1994-08-25 バース、ローレンス・サミュエル 組織の接合およびシール用組成物並びにその使用方法
JPH09107978A (ja) * 1983-12-27 1997-04-28 Genetics Inst Inc 組織プラスミノーゲン活性化因子の生産方法
USRE39192E1 (en) 1990-11-27 2006-07-18 American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
USRE39298E1 (en) 1990-11-27 2006-09-19 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
USRE39321E1 (en) 1990-11-27 2006-10-03 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US7196054B1 (en) 1990-11-27 2007-03-27 The American National Red Cross Methods for treating wound tissue and forming a supplemented fibrin matrix

Families Citing this family (164)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287777A (en) * 1976-09-13 1981-09-08 Bunker Ramo Corporation Semi-automatic contact insertion tool
ATE13810T1 (de) 1981-06-25 1985-07-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundabdeckung.
ATE20824T1 (de) 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
US4600574A (en) * 1984-03-21 1986-07-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of producing a tissue adhesive
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5112805A (en) * 1985-11-22 1992-05-12 Labsystems, Oy Pharmaceutical preparation for promoting epithelial healing and prevention of epithelial destruction
FI854634A0 (fi) * 1985-11-22 1985-11-22 Labsystems Oy Foerfarande foer bestaemning av proteolytisk aktivitet.
US5180583A (en) * 1985-11-26 1993-01-19 Hedner Ulla K E Method for the treatment of bleeding disorders
US4889722A (en) * 1985-12-16 1989-12-26 Ethicon, Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
EP0227400B1 (en) * 1985-12-16 1991-12-04 Ethicon, Inc. Inhibition of post-surgical adhesion formation by the topical administration of tissue plasminogen activator
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
US5260420A (en) * 1987-07-30 1993-11-09 Centre Regional De Transfusion Sanguine De Lille Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof
AT397203B (de) * 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
US4837379A (en) * 1988-06-02 1989-06-06 Organogenesis Inc. Fibrin-collagen tissue equivalents and methods for preparation thereof
US4973466A (en) * 1988-06-21 1990-11-27 Chiron Ophthalmics, Inc. Wound-healing dressings and methods
US5226877A (en) 1989-06-23 1993-07-13 Epstein Gordon H Method and apparatus for preparing fibrinogen adhesive from whole blood
CA2051638A1 (en) * 1989-08-10 1991-02-11 John Richard Hull Medical dispensing system for tissue adhesive components
US5599558A (en) * 1989-09-15 1997-02-04 Curative Technologies, Inc. Selecting amounts of platelet releasate for efficacious treatment of tissue
US5030215A (en) * 1990-01-03 1991-07-09 Cryolife, Inc. Preparation of fibrinogen/factor XIII precipitate
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
US5420250A (en) * 1990-08-06 1995-05-30 Fibrin Corporation Phase transfer process for producing native plasma protein concentrates
US5644032A (en) * 1990-08-06 1997-07-01 Fibrin Corporation Process for producing fibrinogen concentrates
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
WO1992009301A1 (en) * 1990-11-27 1992-06-11 The American National Red Cross Tissue sealant and growth factor containing compositions that promote accelerated wound healing
AU1461592A (en) * 1991-02-07 1992-09-07 Fibratek, Inc. Fibrinogen based adhesive
US6613324B1 (en) * 1991-02-28 2003-09-02 Bristol-Myers Squibb Company Adhesive for the gluing of biological tissues
DK83092D0 (da) * 1992-06-24 1992-06-24 Unes As Fremgangsmaade til udvinding af thrombin
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
ES2182840T3 (es) * 1993-03-30 2003-03-16 Hoechst Japan Factor xiii para el tratamiento de heridas de la piel.
US5795780A (en) * 1993-06-23 1998-08-18 Bristol-Myers Squibb Company Method of use of autologous thrombin blood fraction in a cell culture with keratinocytes
US6057287A (en) * 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
US5583114A (en) 1994-07-27 1996-12-10 Minnesota Mining And Manufacturing Company Adhesive sealant composition
USRE38827E1 (en) 1994-07-27 2005-10-11 3M Innovative Properties Company Adhesive sealant composition
US5585007A (en) 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5643192A (en) * 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
WO1996040174A1 (en) * 1995-06-07 1996-12-19 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
DE19521324C1 (de) * 1995-06-12 1996-10-31 Immuno Ag Gewebeklebstoff und Verwendung desselben als Hämostyptikum
US5948427A (en) * 1996-04-25 1999-09-07 Point Medical Corporation Microparticulate surgical adhesive
DE19617369A1 (de) * 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
WO2000062828A1 (en) 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
GB2318732A (en) * 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
US5844087A (en) 1996-11-05 1998-12-01 Bayer Corporation Method and device for delivering fibrin glue
US6121232A (en) * 1997-01-31 2000-09-19 Omrix Biopharmaceuticals Sa Stabilized mixture comprising fibrinogen
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
AT406120B (de) 1997-08-28 2000-02-25 Immuno Ag Gewebekleber
DE19755023C2 (de) * 1997-12-11 2000-03-09 Celanese Chem Europe Gmbh Katalysator und Verfahren zur Herstellung von Vinylacetat
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
US6884230B1 (en) 1998-03-09 2005-04-26 Baxter International Inc. Dispensing head for a tissue sealant applicator and process of use
US6524568B2 (en) * 1998-06-22 2003-02-25 Cytomedix, Inc. Enriched platelet wound healant
WO1999066797A1 (en) 1998-06-22 1999-12-29 Worden Charles E Enriched platelet wound healant
US20020022588A1 (en) * 1998-06-23 2002-02-21 James Wilkie Methods and compositions for sealing tissue leaks
US6274090B1 (en) 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US6921380B1 (en) 1998-10-01 2005-07-26 Baxter International Inc. Component mixing catheter
AU1617800A (en) * 1998-11-12 2000-05-29 Polymer Biosciences, Inc. Hemostatic polymer useful for rapid blood coagulation and hemostasis
AT500670A1 (de) * 1999-05-19 2006-02-15 Bio & Bio Licensing Sa Arzneimittel zur lokalen anwendung
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
US7078232B2 (en) * 1999-08-19 2006-07-18 Artecel, Inc. Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
US6429013B1 (en) 1999-08-19 2002-08-06 Artecel Science, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US6463335B1 (en) 1999-10-04 2002-10-08 Medtronic, Inc. Temporary medical electrical lead having electrode mounting pad with biodegradable adhesive
ATE432946T1 (de) * 1999-12-23 2009-06-15 Csl Ltd Abtrennung von fibrinogen von plasmaproteasen
EP1301245A4 (en) * 2000-07-17 2007-02-28 Haemacure Corp SPRAY HEAD FOR APPLYING A MIXTURE WITH MULTIPLE COMPONENTS
WO2002030445A2 (en) * 2000-10-13 2002-04-18 Baxter International Inc. Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation
US6648911B1 (en) 2000-11-20 2003-11-18 Avantec Vascular Corporation Method and device for the treatment of vulnerable tissue site
US20030040480A1 (en) * 2001-07-20 2003-02-27 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
KR20040055782A (ko) * 2001-10-03 2004-06-26 크리스토퍼 제이 울버튼 보관-안정한 인간 피브리노겐 용액
CN1617735A (zh) * 2001-12-04 2005-05-18 克里斯托弗·J·伍尔弗顿 贮存稳定性纤维蛋白密封剂
WO2003057072A2 (en) * 2001-12-31 2003-07-17 Ares Laboratories, Llc Hemostatic compositions and methods for controlling bleeding
AU2003226265A1 (en) * 2002-04-05 2003-10-27 Baxter Healthcare S.A. Storage stable liquid sealer protein complex
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
DE10392686T5 (de) 2002-05-24 2005-07-07 Biomet Mfg. Corp., Warsaw Vorrichtung und Verfahren zum Trennen und Konzentrieren von Flüssigkeiten, welche mehrere Komponenten enthalten
DE60333758D1 (de) 2002-06-07 2010-09-23 Dyax Corp Prevention und Verringerung von Ischemia
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
EP2386310B1 (en) * 2002-08-28 2018-11-07 Dyax Corp. Methods for preserving organs and tissues
WO2004024195A1 (en) * 2002-09-10 2004-03-25 American National Red Cross Hemostatic dressing
US8834864B2 (en) 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
EP1784415A2 (en) * 2004-08-27 2007-05-16 Novo Nordisk Health Care AG Purification of factor xiii polypeptides from biological materials
US7235530B2 (en) * 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
JP5086093B2 (ja) 2004-11-23 2012-11-28 ジモジェネティクス、インコーポレイテッド 組換え型ヒトｘｉｉｉ因子の精製
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
US7708152B2 (en) 2005-02-07 2010-05-04 Hanuman Llc Method and apparatus for preparing platelet rich plasma and concentrates thereof
WO2006086199A1 (en) 2005-02-07 2006-08-17 Hanuman Llc Platelet rich plasma concentrate apparatus and method
EP1890820A4 (en) * 2005-03-22 2012-04-11 Cascade Medical Entpr Llc SYSTEMS AND METHOD FOR PRODUCING MEMBRANES
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US20070014780A1 (en) * 2005-07-13 2007-01-18 Statseal Storage-stable human fibrinogen solutions
FR2894831B1 (fr) 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8430813B2 (en) * 2006-05-26 2013-04-30 Depuy Spine, Inc. Illuminated surgical access system including a surgical access device and integrated light emitter
ES2575933T3 (es) 2006-05-31 2016-07-04 Baxter International Inc. Colágeno para su uso en la prevención de la formación de fibrosis epidural después de cirugía espinal
CN101522228A (zh) 2006-08-02 2009-09-02 克赫里昂恩克斯公司 尤其可用于组织填补和瘢痕形成的可植入制剂
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
MX2009001323A (es) * 2006-08-04 2009-07-22 Stb Lifesaving Technologies In Aposito solido para tratar tejido herido.
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
JP5479319B2 (ja) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US20110034954A1 (en) * 2007-04-13 2011-02-10 Pacesetter, Inc. Sutureless reinforcement for and method of treating a myocardial infarction
US20090075891A1 (en) 2007-08-06 2009-03-19 Macphee Martin Methods and dressings for sealing internal injuries
EP2034010A1 (en) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
AR069109A1 (es) 2007-10-30 2009-12-30 Baxter Int Uso de una biomatriz de colageno biofuncional regenerativa para tratar defectos viscerales o parietales
PL2259774T3 (pl) 2008-02-27 2013-04-30 Biomet Biologics Llc Sposoby i kompozycje dla wprowadzania antagonisty receptora interleukiny-1
EP2254991B1 (en) 2008-02-29 2018-08-22 Biomet Manufacturing, LLC A system and process for separating a material
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
JP5292025B2 (ja) * 2008-09-09 2013-09-18 一般財団法人化学及血清療法研究所 カルボン酸含有生体組織接着剤及びその調製方法
CN102307600B (zh) 2008-12-11 2015-11-25 巴克斯特国际公司 以纤维蛋白原和硫酸化多糖为基础的制剂
JP2013516389A (ja) * 2009-01-06 2013-05-13 ダイアックス コーポレーション カリクレイン阻害剤による粘膜炎治療
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
WO2010129258A2 (en) 2009-04-27 2010-11-11 Mallinckrodt Inc. Tissue sealant compositions, vascular closure devices, and uses thereof
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
CN102802683B (zh) 2009-06-16 2015-11-25 巴克斯特国际公司 止血海绵
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
WO2011035020A1 (en) 2009-09-18 2011-03-24 Bioinspire Technologies, Inc. Free-standing biodegradable patch
US9271925B2 (en) 2013-03-11 2016-03-01 Bioinspire Technologies, Inc. Multi-layer biodegradable device having adjustable drug release profile
FR2952641B1 (fr) 2009-11-18 2012-01-13 Lfb Biomedicaments Procede de traitement du plasma sanguin comprenant une etape de lavage par dispersion
CA2784432C (en) 2009-12-16 2019-01-15 Baxter Healthcare S.A. Hemostatic sponge
SI3459564T1 (sl) * 2010-01-06 2022-06-30 Takeda Pharmaceutical Company Limited Proteini, ki vežejo plazemski kalikrein
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US8940335B2 (en) 2010-06-01 2015-01-27 Baxter International Inc. Process for making dry and stable hemostatic compositions
KR101865427B1 (ko) 2010-06-01 2018-06-07 백스터 인터내셔널 인코포레이티드 건성의 안정된 지혈 조성물의 제조 방법
KR101967085B1 (ko) 2010-06-01 2019-04-08 백스터 인터내셔널 인코포레이티드 건조 및 안정한 지혈 조성물의 제조 방법
JP2014506257A (ja) 2011-01-06 2014-03-13 ダイアックス コーポレーション 血漿カリクレイン結合タンパク質
US20140287044A1 (en) * 2011-03-04 2014-09-25 Rare Antibody Antigen Supply, Inc. Fibrin sealant (fibringluraas) consisting of a kit of lyophilized or frozen high concentrate fribinogen
JP6195569B2 (ja) 2011-10-11 2017-09-13 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 止血組成物
EP4137164A1 (en) 2011-10-11 2023-02-22 Baxter International Inc. Hemostatic compositions
PH12014500920A1 (en) * 2011-10-27 2014-06-09 Baxter Healthcare Sa Hemostatic compositions
EP2822474B1 (en) 2012-03-06 2018-05-02 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
KR101567053B1 (ko) 2013-09-30 2015-11-09 한국원자력의학원 방사선 피폭에 의한 간 손상 예측용 바이오마커 및 그 예측방법
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
IL295414B1 (en) 2014-03-27 2025-10-01 Takeda Pharmaceuticals Co Compositions and methods for treating macular edema due to diabetes
AU2015333206B2 (en) 2014-10-13 2019-07-11 Ferrosan Medical Devices A/S. Dry composition for use in haemostasis and wound healing
EP3237041B1 (en) 2014-12-24 2020-01-29 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
CA2986981A1 (en) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US11286307B2 (en) 2015-12-11 2022-03-29 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
EP3790600B1 (en) 2018-05-09 2023-12-27 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition
JP2025504260A (ja) 2021-12-30 2025-02-07 バクスター・インターナショナル・インコーポレイテッド フィブリンシーラント用のフィブリノーゲン溶液及びトロンビン溶液並びにフィブリンシーラントキット

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DIE MEDIZINISCHE WELT=1978 *
J.MAX.FAC.SURG1=1973 *
LANGENBECKS ARCH.CHIR.SUPPL.FORUM=1974 *
WIENER KLINISCHE WOCHENSCHRIFT=1976 *
WIENER MEDIZINISCHE WOCHENSCHRIFT NR37=1972 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826821A (ja) * 1981-07-28 1983-02-17 イムノ・アクチェンゲゼルシャフト 組織接着剤並びにその製造方法
JPH09107978A (ja) * 1983-12-27 1997-04-28 Genetics Inst Inc 組織プラスミノーゲン活性化因子の生産方法
JPS6324951A (ja) * 1986-07-05 1988-02-02 ベ−リングヴエルケ・アクチエンゲゼルシヤフト 一成分組織接着剤およびその製造方法
JPH02114A (ja) * 1987-07-30 1990-01-05 Centre Reg Transfusion Sanguine De Lille トロンビン凝固性蛋白質の濃縮物、その製造方法及びその治療的用途
JPH0196138A (ja) * 1987-10-06 1989-04-14 Green Cross Corp:The 異常破水治療剤
JPH01250326A (ja) * 1988-03-31 1989-10-05 Chemo Sero Therapeut Res Inst ヒト血漿由来血液凝固第ｘ３因子の製造方法
JPH06507376A (ja) * 1990-07-27 1994-08-25 バース、ローレンス・サミュエル 組織の接合およびシール用組成物並びにその使用方法
USRE39192E1 (en) 1990-11-27 2006-07-18 American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
USRE39298E1 (en) 1990-11-27 2006-09-19 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
USRE39321E1 (en) 1990-11-27 2006-10-03 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US7196054B1 (en) 1990-11-27 2007-03-27 The American National Red Cross Methods for treating wound tissue and forming a supplemented fibrin matrix
US7208179B1 (en) 1990-11-27 2007-04-24 The American National Red Cross Methods for treating disease and forming a supplemented fibrin matrix

Also Published As

Publication number Publication date
GB2042556B (en) 1983-04-13
AT359653B (de) 1980-11-25
US4298598A (en) 1981-11-03
NL190748B (nl) 1994-03-01
DK65680A (da) 1980-08-16
NL8000936A (nl) 1980-08-19
SE8902376D0 (sv) 1989-06-30
ES8101382A1 (es) 1980-12-16
DK151611B (da) 1987-12-21
SE463350B (sv) 1990-11-12
IT8019911A0 (it) 1980-02-14
ATA119079A (de) 1980-04-15
FR2448901B1 (cg-RX-API-DMAC7.html) 1984-09-07
GB2042556A (en) 1980-09-24
IT1141212B (it) 1986-10-01
CA1119516A (en) 1982-03-09
SE8000470L (sv) 1980-08-16
SE453800B (sv) 1988-03-07
AR226837A1 (es) 1982-08-31
DE3002933C2 (de) 1984-01-26
JPS6340547B2 (cg-RX-API-DMAC7.html) 1988-08-11
US4377572A (en) 1983-03-22
FR2448901A1 (fr) 1980-09-12
DE3002933A1 (de) 1980-08-28
CH649925A5 (de) 1985-06-28
AR222209A1 (es) 1981-04-30
ES488431A0 (es) 1980-12-16
BE881467A (fr) 1980-05-16

Similar Documents

Publication Publication Date Title
JPS55110556A (en) Tissue adhesive and its preparation
JPS55110557A (en) Tissue adhesive and its preparation
GB2055800B (en) Guanidinothiazoles and their preparation and use
DE2967395D1 (en) Osteosynthesis elements and their preparation
NZ187452A (en) N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation
PH18683A (en) Novel 4-aroylimidazol-2-ones and their use
JPS5663957A (en) Nnazidosulfonylaryllmaleinimide and its use
JPS55117655A (en) Laminate and its preparation
IL60873A0 (en) 4-fluoro-3-phenoxy-benzylethers and their preparation
GB2052488B (en) 3 - vinyl - cephalosporins and their preparation
JPS565207A (en) Tireeliner and its preparation
JPS5477643A (en) Adhesive and its preparation
GB2051062B (en) 3-vinyl-cephalosporin derivatives and their preparation
JPS5570275A (en) Ski and its preparation
JPS5640680A (en) 33methyleneflavanone and 33methylenechromanone and their use
JPS563056A (en) Sanitary good and its preparation
ZA802582B (en) Preparation of aryl-monourethanes and aryl-polyurethanes
JPS5548272A (en) Adhesive and use thereof
GB2004542B (en) Beta-substituted-diketones and preparation thereof
JPS54160088A (en) Cannula and its preparation
JPS55138452A (en) Adhesive bandage
CY1334A (en) 17-cycloalkylmethyl-6-methylene-morphinane derivatives and their preparation
IL60541A0 (en) Tallysomicin derivatives and their preparation
JPS54100845A (en) Gauze nightclothes and its preparation
JPS5441148A (en) Photooreflecting body and its preparation